1. Home
  2. VS vs TOVX Comparison

VS vs TOVX Comparison

Compare VS & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Versus Systems Inc.

VS

Versus Systems Inc.

HOLD

Current Price

$1.19

Market Cap

6.4M

Sector

Technology

ML Signal

HOLD

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.20

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VS
TOVX
Founded
2013
2001
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
7.3M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
VS
TOVX
Price
$1.19
$0.20
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
87.7K
2.6M
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,179,348.00
N/A
Revenue This Year
$3,459.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2281.70
N/A
52 Week Low
$1.15
$0.20
52 Week High
$3.79
$2.08

Technical Indicators

Market Signals
Indicator
VS
TOVX
Relative Strength Index (RSI) 32.94 38.42
Support Level $1.20 $0.21
Resistance Level $1.47 $0.24
Average True Range (ATR) 0.10 0.03
MACD 0.00 0.00
Stochastic Oscillator 18.41 2.42

Price Performance

Historical Comparison
VS
TOVX

About VS Versus Systems Inc.

Versus Systems Inc offers a suite of proprietary business-to-business software tools that are meant to drive user engagement through gamification and rewards. These tools allow its partners to offer in-game prizes and rewards, including merchandise, coupons, digital goods, and sweepstakes entries - inside their websites, their venues, or their streaming media content. Its customers are mostly sports teams, venues, and advertising agencies, which typically use its products as part of their live events or as part of an advertising campaign with the goal of engaging fans, increasing consented first-party data, and increasing sales. The company operates in Canada and the USA.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

Share on Social Networks: